Deborah H. Telman - 10 Jun 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Signature
/s/ Edward S. Son by Power of Attorney for Deborah H. Telman
Issuer symbol
GILD
Transactions as of
10 Jun 2025
Net transactions value
-$47,339
Form type
4
Filing time
11 Jun 2025, 19:01:05 UTC
Previous filing
21 May 2025
Next filing
28 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Telman Deborah H EVP, Corporate Affairs & GC GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY /s/ Edward S. Son by Power of Attorney for Deborah H. Telman 11 Jun 2025 0001860008

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +1,313 +3.6% 38,231 10 Jun 2025 Direct F1
transaction GILD Common Stock Tax liability $47,339 -430 -1.1% $110.09 37,801 10 Jun 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -1,313 -4.1% 30,389 10 Jun 2025 Common Stock 1,313 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.